Pancreatic islet isolation variables in non-human primates (rhesus macaques)

Diabetologia

Volumn 51, Issue 7, 2008, Pages 1236-1244

  Andrades, P ^a,c   Asiedu, C K ^a   Gansuvd, B ^a   Inusah, S ^b   Goodwin, K J ^a   Deckard, L A ^a   Jargal, U ^a   Thomas, J M ^a  

^a Kentucky   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c NONE   (United States)

Author keywords

Islet isolation; Islet transplantation; Non human primates

Indexed keywords

ENDOTOXIN; UNIVERSITY OF WISCONSIN SOLUTION;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CORRELATION ANALYSIS; DATA ANALYSIS; FEMALE; ISOLATED PANCREAS ISLET; MACACA; MALE; MULTIVARIATE ANALYSIS; NONHUMAN; ORGAN DONOR; ORGAN PRESERVATION; OUTCOME ASSESSMENT; PANCREAS ISLET; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PRIMATE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; STREPTOZOCIN DIABETES;

ADENOSINE; ALLOPURINOL; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; FEMALE; GLUTATHIONE; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MACACA MULATTA; MALE; ORGAN CULTURE TECHNIQUES; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; RAFFINOSE;

EID: 44749084860     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-008-1030-z     Document Type: Article

References (37)

1. Shapiro AM, Lakey JR, Ryan EA et al (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238
2. Hering BJ, Kandaswamy R, Ansite JD et al (2005) Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 293:830-835
3. Scharp DW, Murphy JJ, Newton WT, Ballinger WF, Lacy PE (1975) Transplantation of islets of Langerhans in diabetic rhesus monkeys. Surgery 77:100-105
4. Ranuncoli A, Cautero N, Ricordi C et al (2000) Islet cell transplantation: in vivo and in vitro functional assessment of nonhuman primate pancreatic islets. Cell Transplant 9:409-414
5. Gray DW (1990) Islet isolation and transplantation techniques in the primate. Surg Gynecol Obstet 170:225-232
6. O'Neil JJ, Tchipashvili V, Parent RJ et al (2003) A simple and cost-effective method for the isolation of islets from nonhuman primates. Cell Transplant 12:883-890
7. Thomas JM, Contreras JL, Smyth CA et al (2001) Successful reversal of streptozotocin-induced diabetes with stable allogeneic islet function in a preclinical model of type 1 diabetes. Diabetes 50:1227-1236
8. Matsumoto S, Iwanaga Y, Okitsu T et al (2005) Analysis of large-scale nonhuman primate islet isolations. Transplant Proc 37:1317-1321
9. Nano R, Clissi B, Melzi R et al (2005) Islet isolation for allotransplantation: variables associated with successful islet yield and graft function. Diabetologia 48:906-912
10. Shibata S, Kirchhof N, Matsumoto S et al (2002) High-dose streptozotocin for diabetes induction in adult rhesus monkeys. Transplant Proc 34:1341-1344
11. 2) method of pancreas preservation on human islet isolation, as assessed by the Edmonton Isolation Protocol. Transplantation 74:1414-1419
12. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW (1988) Automated method for isolation of human pancreatic islets. Diabetes 37:413-420
13. Kenyon NS, Chatzipetrou M, Masetti M et al (1999) Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci USA 96:8132-8137
14. Ricordi C, Gray DW, Hering BJ et al (1990) Islet isolation assessment in man and large animals. Acta Diabetol Lat 27:185-195
15. Berney T, Molano RD, Cattan P et al (2001) Endotoxin-mediated delayed islet graft function is associated with increased intra-islet cytokine production and islet cell apoptosis. Transplantation 71:125-132
16. Linetsky E, Inverardi L, Kenyon NS, Alejandro R, Ricordi C (1998) Endotoxin contamination of reagents used during isolation and purification of human pancreatic islets. Transplant Proc 30:345-346
17. Lakey JR, Cavanagh TJ, Zieger MA, Wright M (1998) Evaluation of a purified enzyme blend for the recovery and function of canine pancreatic islets. Cell Transplant 7:365-372
18. Dufrane D, D'Hoore W, Goebbels RM, Saliez A, Guiot Y, Gianello P (2006) Parameters favouring successful adult pig islet isolations for xenotransplantation in pig-to-primate models. Xenotransplantation 13:204-214
19. Balamurugan AN, Ramakrishna B, Gunasekaran S (2004) Insulin secretory characteristics of monkey pancreatic islets: a simple method of islet isolation and the effect of various density gradients on separation. Diabetes Res Clin Pract 66:13-21
20. Brandhorst D, Brandhorst H, Hering BJ, Federlin K, Bretzel RG (1995) Islet isolation from the pancreas of large mammals and humans: 10 years of experience. Exp Clin Endocrinol Diabetes 103( Suppl 2):3-14
21. Lakey JR, Warnock GL, Rajotte RV et al (1996) Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation 61:1047-1053
22. Matsumoto S, Zhang G, Qualley S et al (2004) Analysis of donor factors affecting human islet isolation with current isolation protocol. Transplant Proc 36:1034-1036
23. O'Gorman D, Kin T, Murdoch T et al (2005) The standardization of pancreatic donors for islet isolations. Transplantation 80:801-806
24. Matsumoto S, Zhang G, Qualley S et al (2004) The effect of two-layer (University of Wisconsin solution/perfluorochemical) preservation method on clinical grade pancreata prior to islet isolation and transplantation. Transplant Proc 36:1037-1039
25. Fraker CA, Alejandro R, Ricordi C (2002) Use of oxygenated perfluorocarbon toward making every pancreas count. Transplantation 74:1811-1812
26. Lakey JR, Tsujimura T, Shapiro AM, Kuroda Y (2002) Preservation of the human pancreas before islet isolation using a two-layer (UW solution- perfluorochemical) cold storage method. Transplantation 74:1809-1811
27. Yamamoto T, Ricordi C, Messinger S et al (2007) Deterioration and variability of highly purified collagenase blends used in clinical islet isolation. Transplantation 84:997-1002
28. Andrades P, Asiedu C, Ray P et al (2007) Islet yield after different methods of pancreatic Liberase delivery. Transplant Proc 39:183-184
29. Jahr H, Pfeiffer G, Hering BJ, Federlin K, Bretzel RG (1999) Endotoxin-mediated activation of cytokine production in human PBMCs by collagenase and Ficoll. J Mol Med 77:118-120
30. Linetsky E, Bottino R, Lehmann R, Alejandro R, Inverardi L, Ricordi C (1997) Improved human islet isolation using a new enzyme blend, liberase. Diabetes 46:1120-1123
31. Vargas F, Vives-Pi M, Somoza N et al (1998) Endotoxin contamination may be responsible for the unexplained failure of human pancreatic islet transplantation. Transplantation 65:722-727
32. Vives-Pi M, Somoza N, Fernandez-Alvarez J et al (2003) Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells. Clin Exp Immunol 133:208-218
33. Petsch D, Anspach FB (2000) Endotoxin removal from protein solutions. J Biotechnol 76:97-119
34. Zimmer S, Pollard V, Marshall GD et al (1996) The 1996 Moyer Award. Effects of endotoxin on the Th1/Th2 response in humans. J Burn Care Rehabil 17:491-496
35. Saito Y, Yanagawa Y, Kikuchi K, Iijima N, Iwabuchi K, Onoe K (2006) Low-dose lipopolysaccharide modifies the production of IL-12 by dendritic cells in response to various cytokines. J Clin Exp Hematop 46:31-36
36. Selvaggi G, Fernandez L, Bottino R et al (1997) Improved baboon pancreatic islet cell isolation. Transplant Proc 29:1967-1968
37. Kim SC, Han DJ, Kang CH et al (2005) Analysis on donor and isolation-related factors of successful isolation of human islet of Langerhans from human cadaveric donors. Transplant Proc 37:3402-3403